Cargando…
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736269/ https://www.ncbi.nlm.nih.gov/pubmed/34968373 http://dx.doi.org/10.15585/mmwr.mm705152a2 |
| _version_ | 1784628431003058176 |
|---|---|
| author | Lutrick, Karen Rivers, Patrick Yoo, Young M. Grant, Lauren Hollister, James Jovel, Krystal Khan, Sana Lowe, Ashley Baccam, Zoe Hanson, Hanna Olsho, Lauren E.W. Fowlkes, Ashley Caban-Martinez, Alberto J. Porter, Cynthia Yoon, Sarang Meece, Jennifer Gaglani, Manjusha Burns, Joy Mayo Lamberte, Julie Nakayima Miiro, Flavia Bissonnette, Adam LeClair, Lindsay Kutty, Preeta K. Romine, James K. Stefanski, Elisha Edwards, Laura J. Ellingson, Katherine Gerald, Joe K. Bedrick, Edward J. Madhivanan, Purnima Krupp, Karl Gerald, Lynn B. Thompson, Mark Burgess, Jefferey L. |
| author_facet | Lutrick, Karen Rivers, Patrick Yoo, Young M. Grant, Lauren Hollister, James Jovel, Krystal Khan, Sana Lowe, Ashley Baccam, Zoe Hanson, Hanna Olsho, Lauren E.W. Fowlkes, Ashley Caban-Martinez, Alberto J. Porter, Cynthia Yoon, Sarang Meece, Jennifer Gaglani, Manjusha Burns, Joy Mayo Lamberte, Julie Nakayima Miiro, Flavia Bissonnette, Adam LeClair, Lindsay Kutty, Preeta K. Romine, James K. Stefanski, Elisha Edwards, Laura J. Ellingson, Katherine Gerald, Joe K. Bedrick, Edward J. Madhivanan, Purnima Krupp, Karl Gerald, Lynn B. Thompson, Mark Burgess, Jefferey L. |
| author_sort | Lutrick, Karen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8736269 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87362692022-01-14 Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021 Lutrick, Karen Rivers, Patrick Yoo, Young M. Grant, Lauren Hollister, James Jovel, Krystal Khan, Sana Lowe, Ashley Baccam, Zoe Hanson, Hanna Olsho, Lauren E.W. Fowlkes, Ashley Caban-Martinez, Alberto J. Porter, Cynthia Yoon, Sarang Meece, Jennifer Gaglani, Manjusha Burns, Joy Mayo Lamberte, Julie Nakayima Miiro, Flavia Bissonnette, Adam LeClair, Lindsay Kutty, Preeta K. Romine, James K. Stefanski, Elisha Edwards, Laura J. Ellingson, Katherine Gerald, Joe K. Bedrick, Edward J. Madhivanan, Purnima Krupp, Karl Gerald, Lynn B. Thompson, Mark Burgess, Jefferey L. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2021-12-31 /pmc/articles/PMC8736269/ /pubmed/34968373 http://dx.doi.org/10.15585/mmwr.mm705152a2 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Lutrick, Karen Rivers, Patrick Yoo, Young M. Grant, Lauren Hollister, James Jovel, Krystal Khan, Sana Lowe, Ashley Baccam, Zoe Hanson, Hanna Olsho, Lauren E.W. Fowlkes, Ashley Caban-Martinez, Alberto J. Porter, Cynthia Yoon, Sarang Meece, Jennifer Gaglani, Manjusha Burns, Joy Mayo Lamberte, Julie Nakayima Miiro, Flavia Bissonnette, Adam LeClair, Lindsay Kutty, Preeta K. Romine, James K. Stefanski, Elisha Edwards, Laura J. Ellingson, Katherine Gerald, Joe K. Bedrick, Edward J. Madhivanan, Purnima Krupp, Karl Gerald, Lynn B. Thompson, Mark Burgess, Jefferey L. Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021 |
| title | Interim Estimate of Vaccine Effectiveness of BNT162b2
(Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents
Aged 12–17 Years — Arizona, July–December
2021 |
| title_full | Interim Estimate of Vaccine Effectiveness of BNT162b2
(Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents
Aged 12–17 Years — Arizona, July–December
2021 |
| title_fullStr | Interim Estimate of Vaccine Effectiveness of BNT162b2
(Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents
Aged 12–17 Years — Arizona, July–December
2021 |
| title_full_unstemmed | Interim Estimate of Vaccine Effectiveness of BNT162b2
(Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents
Aged 12–17 Years — Arizona, July–December
2021 |
| title_short | Interim Estimate of Vaccine Effectiveness of BNT162b2
(Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents
Aged 12–17 Years — Arizona, July–December
2021 |
| title_sort | interim estimate of vaccine effectiveness of bnt162b2
(pfizer-biontech) vaccine in preventing sars-cov-2 infection among adolescents
aged 12–17 years — arizona, july–december
2021 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736269/ https://www.ncbi.nlm.nih.gov/pubmed/34968373 http://dx.doi.org/10.15585/mmwr.mm705152a2 |
| work_keys_str_mv | AT lutrickkaren interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT riverspatrick interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT yooyoungm interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT grantlauren interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT hollisterjames interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT jovelkrystal interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT khansana interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT loweashley interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT baccamzoe interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT hansonhanna interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT olsholaurenew interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT fowlkesashley interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT cabanmartinezalbertoj interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT portercynthia interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT yoonsarang interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT meecejennifer interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT gaglanimanjusha interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT burnsjoy interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT mayolambertejulie interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT nakayimamiiroflavia interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT bissonnetteadam interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT leclairlindsay interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT kuttypreetak interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT rominejamesk interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT stefanskielisha interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT edwardslauraj interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT ellingsonkatherine interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT geraldjoek interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT bedrickedwardj interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT madhivananpurnima interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT kruppkarl interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT geraldlynnb interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT thompsonmark interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 AT burgessjeffereyl interimestimateofvaccineeffectivenessofbnt162b2pfizerbiontechvaccineinpreventingsarscov2infectionamongadolescentsaged1217yearsarizonajulydecember2021 |